|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
ImmuneXpress Inc.
| | | Phone: | (206) 858-6436 | Year Established: | 2010 | Main Contact: | Roslyn Brandon, Ph.D., President & CEO | | Other Contacts: | Richard Brandon, Ph.D., MBA, Co-Founder & CSO Greg Uhl, Director, Finance Leo McHugh, Director, Business Development Roy Davis, MD, PhD, MHA, CMO Thomas Yager, Director, R&D
| | Company Description | Immunexpress is a privately-held group of companies with locations in Brisbane, Australia and Seattle, WA. Immunexpress started in Brisbane in 2006 as Athlomics Pty Ltd, and rebranded in 2011 as Immunexpress. Through a wholly-owned subsidiary, Immunexpress Inc., it now operates its business development office from Seattle, Washington.
Immunexpress’s core competency is the discovery and clinical validation of genomic and proteomic biomarkers, and the translation of these novel biomarkers into clinical diagnostic and monitoring assays for readily available platforms, including point-of-care (POC).
Immunexpress SeptiCyte® technology is currently being developed for use by critical care clinicians in hospitals for the improved personalized management of patients with, or at risk of, sepsis. SeptiCyte® quantifies specific and multiple molecular markers from the patient’s own immune system (‘host response’) for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. | |
|
|
|
|
|